三黄汤治疗单纯性肥胖症临床观察

Clinical Study of Sanhuang Decoction in Treating Obesity

The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China

摘要: 目的观察三黄汤对单纯性肥胖症患者体质量及代谢指标的影响。方法将64例痰湿热结型单纯性肥胖症患者随机分为中药组（34例）和生活方式干预对照组（30例），对照组进行饮食控制和运动，中药组在生活方式干预的基础上，给予三黄汤口服，进行了3月的疗效观察，对治疗前后临床症状、体质量指标、糖脂代谢指标及炎症因子等进行比较分析。结果中药组在改善患者临床症状及降低体质量、腰围、TG水平等方面优于对照组（P<0.05）。结论三黄汤干预肥胖症临床疗效优于对照组。
- 肥胖 /
- 三黄汤 /
- 炎症因子
Abstract: OBJECTIVE To observe the effect of Sanhuang decoction in the body mass and metabolic index of patients with obesity. METHODS 64 Patients conformed to western medicine diagnosis of obesity and phlegm， dampness and heat junction were randomly divided into Sanhuang decotion group and lifestyle intervention group. After three months of treatment，comparative analysis of clinical symptoms，body mass index， waist， glucose and lipid metabolism factors and inflammatory cytokine were carried out. RESULTS Sanhuang decoction group showed better improvement in lowering body mass， waist， TG levels than the control group(P<0.05). CONCLUSION Sanhuang decoction is better in treating obesity.
- obesity /
- Sanhuang decoction /
- inflammatory cytokine

[1]	Flegal KM， Carroll MD， Ogden CL. Prevalence and trends in obesity among US adults， 1999-2008[J]. JAMA， 2010， 303(3): 235-241.
[2]	中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志，2002，23(1):5-10.
[3]	China's Obesity Data Summary and Analysis Group. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population[J]. Chin J Epidemiol， 2002， 23(1):5-10.
[4]	中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002：233-235.
[5]	Clinical Guideline of New Drugs for Traditional Chinese Medicine[M]. Beijing: China medical science press， 2002: 233-235.